Works in Cancer Chemotherapy & Pharmacology, 2021, Vol 87, Issue 5

Results: 15

Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 701, doi. 10.1007/s00280-021-04243-z
By:
- Liu, Yang;
- Cao, Yongde;
- Xiao, Leting;
- Wang, Haijiang
Publication type:
Article
Anticancer potential of metformin: focusing on gastrointestinal cancers.
Published in:
2021
By:
- Khezri, Mohammad rafi;
- Melekinejad, Hassan;
- Majidi-Zolbanin, Naime;
- Ghasemnejad-Berenji, Morteza;
- Malekinejad, Hassan
Publication type:
journal article
Carboxylesterase 1 polymorphisms are associated with clinical outcomes in gastroenteric cancer patients treated with capecitabine.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 681, doi. 10.1007/s00280-021-04247-9
By:
- Liu, Duo;
- Li, Xuehua;
- Li, Xiang;
- Wang, Huiqi;
- Dong, Mei
Publication type:
Article
Phase I study of JAK1/2 inhibitor ruxolitinib with weekly paclitaxel for the treatment of HER2-negative metastatic breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 673, doi. 10.1007/s00280-021-04245-x
By:
- Lynce, Filipa;
- Williams, James T.;
- Regan, Meredith M.;
- Bunnell, Craig A.;
- Freedman, Rachel A.;
- Tolaney, Sara M.;
- Chen, Wendy Y.;
- Mayer, Erica L.;
- Partridge, Ann H.;
- Winer, Eric P.;
- Overmoyer, Beth
Publication type:
Article
Detecting DPD deficiency: when perfect is the enemy of good.
Published in:
2021
By:
- Ciccolini, Joseph;
- Milano, Gérard;
- Guchelaar, Henk-Jan
Publication type:
Letter
Comparison of a thymine challenge test and endogenous uracil-dihydrouracil levels for assessment of fluoropyrimidine toxicity risk.
Published in:
2021
By:
- Burns, Kathryn E.;
- Chavani, Ottiniel;
- Jeong, Soo Hee;
- Duley, John A.;
- Porter, David;
- Findlay, Michael;
- Strother, R. Matthew;
- Helsby, Nuala A.
Publication type:
journal article
Trilaciclib dose selection: an integrated pharmacokinetic and pharmacodynamic analysis of preclinical data and Phase Ib/IIa studies in patients with extensive-stage small cell lung cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 689, doi. 10.1007/s00280-021-04239-9
By:
- Li, Chao;
- Hart, Lowell;
- Owonikoko, Taofeek K.;
- Aljumaily, Raid;
- Rocha Lima, Caio Max;
- Conkling, Paul R.;
- Webb, Roy Timothy;
- Jotte, Robert M.;
- Schuster, Steven;
- Edenfield, William J.;
- Smith, Deborah A.;
- Sale, Mark;
- Roberts, Patrick J.;
- Malik, Rajesh K.;
- Sorrentino, Jessica A.
Publication type:
Article
Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 647, doi. 10.1007/s00280-021-04238-w
By:
- Yi, Xianglan;
- Lou, Liping;
- Wang, Jun;
- Xiong, Jing;
- Zhou, Sheng
Publication type:
Article
Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 657, doi. 10.1007/s00280-021-04236-y
By:
- Saarenheimo, Jatta;
- Wahid, Nesna;
- Eigeliene, Natalja;
- Ravi, Ravichandra;
- Salomons, Gajja S.;
- Ojeda, Matilde Fernandez;
- Vijzelaar, Raymon;
- Jekunen, Antti;
- van Kuilenburg, André B. P.
Publication type:
Article
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
Published in:
2021
By:
- Ishibashi, Keiichiro;
- Aoyama, Toru;
- Kotaka, Masahito;
- Satake, Hironaga;
- Tsuji, Yasushi;
- Kataoka, Masato;
- Nakamura, Masato;
- Nagata, Naoki;
- Sakamoto, Junichi;
- Oba, Koji;
- Mishima, Hideyuki
Publication type:
journal article
A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 599, doi. 10.1007/s00280-020-04229-3
By:
- Collier, Katharine A.;
- Valencia, Hugo;
- Newton, Herbert;
- Hade, Erinn M.;
- Sborov, Douglas W.;
- Cavaliere, Robert;
- Poi, Ming;
- Phelps, Mitch A.;
- Liva, Sophia G.;
- Coss, Christopher C.;
- Wang, Jiang;
- Khountham, Soun;
- Monk, Paul;
- Shapiro, Charles L.;
- Piekarz, Richard;
- Hofmeister, Craig C.;
- Welling, D. Bradley;
- Mortazavi, Amir
Publication type:
Article
A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 613, doi. 10.1007/s00280-020-04225-7
By:
- Sarkar, Sunit;
- Tran, Ben;
- Horvath, Lisa;
- Lam, Michael;
- Savas, Peter;
- Grimison, Peter;
- Whittle, James R.;
- Kuo, James C.;
- Signal, Nicole;
- Edmonds, David;
- Hogg, Philip;
- Rischin, Danny;
- Desai, Jayesh;
- Hamilton, Anne
Publication type:
Article
Evaluating clinical impact of a shortened infusion duration for ramucirumab: a model-based approach.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 635, doi. 10.1007/s00280-020-04223-9
By:
- Gao, Ling;
- Lau, Yiu-Keung;
- Wei, Ran;
- O'Brien, Lisa;
- Long, Amanda;
- Piao, Yongzhe;
- Abada, Paolo
Publication type:
Article
Extrapolation of pharmacokinetics and pharmacodynamics of sunitinib in children with gastrointestinal stromal tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 621, doi. 10.1007/s00280-020-04221-x
By:
- Khosravan, Reza;
- DuBois, Steven G.;
- Janeway, Katherine;
- Wang, Erjian
Publication type:
Article
Retraction Note to: Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR‑181 level.
Published in:
Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 5, p. 721, doi. 10.1007/s00280-020-04166-1
By:
- Gong, Anjing;
- Ge, Na;
- Yao, Weicheng;
- Lu, Luxiang;
- Liang, Hui
Publication type:
Article